These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38622341)

  • 41. Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
    Bae EH; Ma SK; Lee J; Kim SW
    Regul Pept; 2011 Oct; 170(1-3):31-7. PubMed ID: 21616096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome.
    Valentin JP; Ying WZ; Couser WG; Humphreys MH
    Am J Physiol; 1998 Mar; 274(3):F556-63. PubMed ID: 9530272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of atrial natriuretic peptide on angiotensin II-induced antinatriuresis in anesthetized dogs.
    Tomura Y; Hisa H; Satoh S
    Biol Pharm Bull; 1995 Sep; 18(9):1211-4. PubMed ID: 8845807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
    Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
    J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation.
    Ge W; Hou C; Zhang W; Guo X; Gao P; Song X; Gao R; Liu Y; Guo W; Li B; Zhao H; Wang J
    J Mol Cell Cardiol; 2021 Mar; 152():52-68. PubMed ID: 33301800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation in
    Cheng C; Liu H; Tan C; Tong D; Zhao Y; Liu X; Si W; Wang L; Liang L; Li J; Wang C; Chen Q; Du Y; Wang QK; Ren X
    FASEB J; 2019 Aug; 33(8):8878-8891. PubMed ID: 31034774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II and atrial natriuretic peptide in the cow oviductal contraction in vitro: direct effect and local secretion of prostaglandins, endothelin-1, and angiotensin II.
    Wijayagunawardane MP; Miyamoto A; Taquahashi Y; Acosta TJ; Nishimura M; Sato K
    Biol Reprod; 2001 Sep; 65(3):799-804. PubMed ID: 11514344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible modulatory role of angiotensin II on atrial peptide-induced natriuresis.
    Salazar FJ; Granger JP; Fiksen-Olsen MJ; Bentley MD; Romero JC
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F880-3. PubMed ID: 2961275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
    Dai YJ; Gong JX; Bian R
    Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of atrial natriuretic peptide, angiotensin II and III on norepinephrine uptake in the rat adrenal medulla.
    Vatta MS; Bianciotti LG; Fernández BE
    Rev Esp Fisiol; 1992 Sep; 48(3):185-9. PubMed ID: 1301634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H; Nielsen CB; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial natriuretic peptide suppresses Th17 development through regulation of cGMP-dependent protein kinase and PI3K-Akt signaling pathways.
    Ma L; Li J; Wang G; Gong S; Zhang L; Li K; Ji X; Liu Y; Chen P; Xiang X
    Regul Pept; 2013 Feb; 181():9-16. PubMed ID: 23327998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of TREM-1 ameliorates angiotensin II-induced atrial fibrillation by attenuating macrophage infiltration and inflammation through the PI3K/AKT/FoxO3a signaling pathway.
    Chen X; Yu L; Meng S; Zhao J; Huang X; Wang Z; Zhou Z; Huang Y; Hong T; Duan J; Su T; Cao Z; Chi Y; Huang T; Wang H
    Cell Signal; 2024 Dec; 124():111458. PubMed ID: 39384003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth.
    Sarzani R; Marcucci P; Salvi F; Bordicchia M; Espinosa E; Mucci L; Lorenzetti B; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    Int J Obes (Lond); 2008 Feb; 32(2):259-67. PubMed ID: 17878892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
    Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LongShengZhi alleviated cardiac remodeling via upregulation microRNA-150-5p with matrix metalloproteinase 14 as the target.
    Gu Y; Zhang S; Chen X; Li Y; Liu Y
    J Ethnopharmacol; 2022 Jun; 291():115156. PubMed ID: 35245628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes.
    O'Tierney PF; Chattergoon NN; Louey S; Giraud GD; Thornburg KL
    J Physiol; 2010 Aug; 588(Pt 15):2879-89. PubMed ID: 20519318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.